RxDoctor Payments Data

Allison King, NP

Nurse Practitioner · Bartlett, TNNPI 1609027465

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $11,198 of the $14,367 with a category attached, or 77.9%. It is spread thinly across 28 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,367in general payments, 2019–2025

Across 654 payments — averaging $21.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Johnson & Johnson$2K
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$2K
  • Incyte Corporation$1K
  • Novartis$1K
  • LEO Pharma Inc.$681
  • plus $5K from 22 others

What the payments were for

  • Consulting fees$2,77519%
  • Food & beverage$11,19878%
  • Education$3943%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,367 in reported general payments places this provider in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$353,882
Medicare patients
1,316
Services billed
7,838

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab13$176,389
RinvoqUpadacitinib13$81,805
Clobetasol Propionate38$1,863
Doxycycline Hyclate39$786
Metronidazole17$771
Triamcinolone Acetonide59$627
Spironolactone26$546
ValacyclovirValacyclovir Hcl28$374
Ketoconazole22$327
Mometasone Furoate18$291
Minocycline Hcl18$263
Minoxidil19$185
Terbinafine Hcl11$86

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$2,853$81,80513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Bartlett

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →